Collins Cooper C. 4
4 · TherapeuticsMD, Inc. · Filed Aug 23, 2024
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2024-08-21$1.70/sh+1,200$2,039→ 47,922 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.685 through $1.70, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.